April 18, 2017 / 11:14 AM / 3 months ago

BRIEF-Genmab Q1 net sales of Darzalex at $255 million

1 Min Read

April 18 (Reuters) - GENMAB A/S

* GENMAB ANNOUNCES NET SALES OF DARZALEX®(DARATUMUMAB) FOR FIRST QUARTER OF 2017

* Net Sales of Darzalex in q1 of 2017 Totaled $255 Million

* SAYS WILL RECEIVE ROYALTIES ON WORLDWIDE NET SALES FROM JANSSEN BIOTECH, INC Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below